Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tumor Neoantigen-Specific T Cells
- Molecular classification
- Immune cell, T lymphocyte, CD8+ T cell, CD4+ T cell
01
Overview
Tumor neoantigen-specific T cells are a subset of T lymphocytes that recognize and respond to neoantigens—novel peptide sequences generated by tumor-specific mutations. These neoantigens are not present in normal tissues, making them highly immunogenic and ideal targets for cancer immunotherapy. Both CD8+ (cytotoxic) and CD4+ (helper) T cells can be specific for tumor neoantigens, mediating direct tumor cell killing or supporting antitumor immune responses.
02
Mechanism of action
Recognize neoantigen-MHC complexes, leading to T cell activation, proliferation, and tumor cell lysis.
03
Biological functions
Antigen recognitionCytotoxicityCytokine secretionImmune responseTumor cell killingT cell activationT cell proliferation
04
Disease associations
Cancer
05
Safety considerations
Functional exhaustionOff-target effects (rare due to neoantigen specificity)Cytokine release syndrome (CRS)
06
Interacting drugs
Immune checkpoint inhibitors (e.g., anti-PD-1, anti-CTLA-4)
1 more in the full profile.
07
Biomarkers
Frequency of neoantigen-specific T cellsTCR clonalityExpression of exhaustion markers (e.g., PD-1)
Beyond the preview
Go deeper on Tumor Neoantigen-Specific T Cells.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Tumor Neoantigen-Specific T Cells.